Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Robert Davis
Age : 55
Public asset : 32,311,517 USD
Country of residence : Unknown
Linked companies : Merck & Co., Inc. - Duke Energy Corporation

Biography of Robert Davis 
Mr. Robert M. Davis is an Independent Director at Duke Energy Corp., a President at Merck & Co., Inc. and a Chairman at Gambro AB. He is on the Board of Directors at Duke Energy Corp., AdvaMedDx, Project HOPE-The-People-To-People HealthFoundation, Inc. and Rush University Medical Center. Mr. Davis was previously employed as a Chief Financial Officer & Vice President by Baxter Healthcare Corp., a VP & President-Medical Products Business by Baxter International, Inc., and a Director-Corporate Financial Planning by Eli Lilly & Co. He also served on the board at C. R. Bard, Inc. (New Jersey). He received his undergraduate degree from Miami University, a graduate degree from Northwestern University School of Law and an MBA from Kellogg School of Management.


Current positions of Robert Davis 
Holdings of Robert Davis 
Robert Davis : Personal Network 
Most Read News 
05/30Stellantis will need one or two additional U.S. battery plants - Tavares
RE
05/29Republicans speak out against US debt-ceiling deal, in sign of rocky road ahead
RE
06/02JPMorgan's Dimon visits Taiwan to meet staff, clients -source
RE
05/22Bill Gates says top AI agent poised to replace search, shopping businesses
RE
05/30Elon Musk kicks off China visit, Tesla expansion in focus
RE
06/01Stellantis does not need Italy among its shareholders, Chairman Elkann says
RE
06/01Activist fund Trian reorders top ranks as CIO Garden retires -filing
RE
05/31Elon Musk greeted with flattery and feasts during China trip
RE
05/25Fresenius lifts 2023 outlook for hospital drugs unit Kabi
RE
06/01LVMH chief Bernard Arnault to visit China in June -sources
RE
More news


© 2023 People and Ownership :   
Robert Davis : Connections 


Latest news about Robert Davis 
05/23Transcript : Merck & Co., Inc. - Shareholder/Analyst Call
CI
05/04Transcript : Integra LifeSciences Holdings Corporation - Analyst/Investor Day
CI
04/27Drugmakers scout for deals, ramp up research spending
RE
04/27Drugmakers scout for deals, ramp up research spending
RE
04/27Transcript : Merck & Co., Inc., Q1 2023 Earnings Call, Apr 27, 2023
CI
04/17Merck & Co., Inc., Prometheus Biosciences, Inc. - M&A Call
CI
04/17Merck Buying Prometheus Biosciences for $10.8 Billion to Enhance Immunology Portfolio
MT
More news

Stock markets for all
100% Free Registration
fermer